Computational Signal Detection laboratories – CSD Labs

About CSD Labs

FOUNDED IN 2014 BY PHYSICIST & BIOMEDICAL ENGINEER DR. ANDREAS SCHRIEFL AND COMPUTER SCIENTIST & BIOMEDICAL ENGINEER ANDREAS REINISCH, CSD LABS DEVELOPS HIGH-END MEDICAL TECHNOLOGY APPLICATIONS BY COMBINING MACHINE INTELLIGENCE WITH STATE OF THE ART COMPUTATIONAL ENGINEERING APPROACHES AND IN-HOUSE PIONEERING RESEARCH & DEVELOPMENT.

CSD Labs is at the forefront of innovation in the analysis and classification of complex human data. The company specializes in Machine Intelligence approaches, ranging from classic AI, simple neural networks and visual processing, to state of the art prediction classifiers.
That, combined with patent-pending technologies, a deep understanding of associated clinical data, and the company’s in-house expertise on the legal requirements dictated by medical device regulations, makes CSD Labs a pioneer in applying Machine Intelligence to medical device applications.

A great team for success

People and Partners

We’re Hiring, Join Us. We’re looking for:

US Business Development Representative

Take a look at our leaders, key advisors and funding partners.

Leadership

 

Founder and CEO

Andreas Schriefl

 

Co-founder and CTO

Andreas Reinisch

 

EVP Business Development

Michael Farrell

Advisors

 

Medical Advisor

Andrew Redington, MD

Executive Co-Director, Heart Institute
Chief, Pediatric Cardiology, Cincinnati Children’s Hospital
Professor, UC Dept of Pediatrics

 

Medical Advisor

Lillian Lai, MD

Cardiologist, CHEO Hospital
Assistant Professor, University of Ottawa

 

Technology Advisor

Pat Beirne

Expert in Systems Engineering
Former VP Engineering at COREL
Authority in the design & production of software

 

Partners

partner_logos

Buzz surrounding eMurmur

Press

Our promotional materials for members of the media and latest news

Press Kit

Download-Icon

COMPANY FACT SHEET

A summary of facts and figures about CSD Labs

-->DOWNLOAD
Download-Icon

TECHNOLOGY PROFILE

eMurmur illustrated and explained

-->DOWNLOAD
Download-Icon

CEO PROFILE

Three things to know about Andreas Schriefl

-->DOWNLOAD

eMurmur Press Room

 

2016/10/25

Clinical Study Results using eMurmur

GRAZ, Austria, Nov. 14, 2016—Computational Signal Detection (CSD) Laboratories LLC cited today the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children, up to 90% of whom will have a heart murmur at some point during their infancy or childhood. However, the majority of these heart murmurs detected in children will be clinically insignificant. In this pilot study of 106 children at Children’s Hospital of Eastern Ontario, eMurmur differentiated pathologic from innocent heart murmurs with high sensitivity (87%) and specificity (100%), a positive predictive value of 100%, a negative predictive value of 90%, and high accuracy (94%) when compared with echocardiography as the gold standard for diagnosing murmurs. Read moreGRAZ, Austria, Nov. 14, 2016—Computational Signal Detection (CSD) Laboratories LLC cited today the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children, up to 90% of whom will have a heart murmur at some point during their infancy or childhood. However, the majority of these heart murmurs detected in children will be clinically insignificant. In this pilot study of 106 children at Children’s Hospital of Eastern Ontario, eMurmur differentiated pathologic from innocent heart murmurs with high sensitivity (87%) and specificity (100%), a positive predictive value of 100%, a negative predictive value of 90%, and high accuracy (94%) when compared with echocardiography as the gold standard for diagnosing murmurs. Read more